MTS Medication Technologies received $13,000,000 for working capital from LaSalle Bank and Berwind Growth Capital

MTS Medication Technologies

received $13,000,000 for
working capital from

LaSalle Bank and
Berwind Growth Capital

FOCUS Partner James C. Harper assisted in the negotiations as the representative of MTS Medication Technologies.
Inside the Deal
Deal Type: Corporate Finance
Client(s)
MTS Medication Technologies
St. Petersburg, FL, U.S.A.
Transaction Partner(s)
LaSalle Bank
U.S.A.
Berwind Growth Capital
U.S.A.
FOCUS Teams Involved